ClearPoint Neuro (CLPT) stock, explained like you're 5

Is ClearPoint Neuro a small, medium or large cap company?

No. ClearPoint Neuro is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 320 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How ClearPoint Neuro makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves CLPT stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment (Yahoo Finance)
• ClearPoint Neuro (NasdaqCM:CLPT) Stock Forecast & Analyst Predictions (Simply Wall Street)
• Why I've (Reluctantly) Sold My ClearPoint Neuro Position (NASDAQ:CLPT) (Seeking Alpha)
• (CLPT) Movement as an Input in Quant Signal Sets (Stock Traders Daily)
• CLPT Forecast Price Target Prediction for 2027 (TradingView)

Key terms to know before you follow CLPT

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility